Archives

We are happy to share the latest ERN ReCONNET newsletter (December 2025 edition) with our community! This issue looks back at a very active year for the network and brings together updates, [...]

The Undifferentiated Connective Tissue Disease (UCTD) Disease Group is pleased to welcome Chiara Tani, who, alongside Cristina Pamfil and ePAG Ramona Luciu, joins the coordination of the [...]

The year 2025 has been a period of significant productivity for the Systemic Sclerosis (SSc) Disease Group, marked by the completion of key projects and the launch of initiatives vital to [...]

The year 2025 has been a period of significant momentum and consolidation for the Sjögren’s Disease (SjD) Group, during which projects launched progressed significantly thanks to dynamic [...]

The year 2025 has been a period of significant progress for the Mixed Connective Tissue Disease (MCTD) Disease Group, marked by the completion of major educational and research milestones. A [...]

Throughout 2025, the ERN ReCONNET Idiopathic Inflammatory Myopathies (IIMs) Disease Group has achieved significant milestones in education, clinical research, and data standardization. A [...]

The main successes achieved include the launch of the initiative “ERN ReCONNET points to consider for the use of imaging in IgG4-RD“. This project aims to create a position statement [...]

Throughout 2025, the ERN ReCONNET Ehlers-Danlos Syndromes (EDS) Disease Group has significantly advanced its efforts to refine the diagnosis and management of generalized joint hypermobility [...]

The APS Disease Group continues to strengthen its activities and collaborative efforts across ERN ReCONNET, and we are pleased to share the latest developments as we move through 2025. One of the [...]

ERN ReCONNET is pleased to announce that Zoe Karakikla-Mitsakou, representing Lupus Europe, has joined ERN ReCONNET as an ePAG Advocate and will contribute her expertise and patient perspective. [...]